Irani Farzin, Dankert Mary, Siegel Steven J
Division of Neuropsychiatry, University of Pennsylvania, Clinical Research Building, Room 145a, 415 Curie Boulevard, Philadelphia, PA 19104, USA.
Curr Psychiatry Rep. 2004 Aug;6(4):283-8. doi: 10.1007/s11920-004-0078-9.
Patient and family member attitudes toward illness, psychopharmacologic and nonpharmacologic treatments in schizophrenia, as well as their attitudes toward psychiatric research are reviewed here. The authors' recent work investigating patient and family member attitudes toward illness, medication, and a new method of receiving medication via surgical implants is also presented. The authors highlight the importance of understanding patient attitudes so that individual treatment plans and new treatments for schizophrenia can be facilitated. The important contribution of family members in caring for their loved ones is also emphasized. Patient participation in biomedical research is also discussed in the context of guiding the treatment of schizophrenia.
本文综述了患者及家属对精神分裂症的疾病态度、心理药物治疗和非药物治疗，以及他们对精神病学研究的态度。还介绍了作者最近关于调查患者及家属对疾病、药物治疗以及通过手术植入接受药物的新方法的态度的研究工作。作者强调了理解患者态度的重要性，以便推动精神分裂症的个体化治疗方案和新治疗方法的发展。还强调了家庭成员在照顾亲人方面的重要贡献。在指导精神分裂症治疗的背景下，也讨论了患者参与生物医学研究的问题。
